|
⚲
|
| Keyboard |
| Marks Gilbert Lynn
✚
|
|
|---|---|
| CIK # | 0001916940 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001916940] | |
| 4 | [0001916940] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Marks Gilbert Lynn |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 10,665 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 10,665 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2026-02-20 | Grant | 20,400 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2026-01-12 | Grant | 11,560 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-10-10 | Grant | 10,367 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-07-10 | Grant | 11,875 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2025-05-22 | Grant | 19,111 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2025-04-10 | Grant | 9,705 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Common Stock
|
2024-12-19 | Grant | 8,972 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (Right to Buy) · derivative
|
2024-06-19 | Grant | 64,503 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2023-06-07 | Grant | 23,742 | $0.00 | |
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2022-05-12 | Grant | 10,362 | $0.00 |